Cuba creates lung cancer vaccine

Cuba’s Centre for Molecular Immunology (CIM) has patented a new therapeutic lung cancer vaccine, according to Ana Maria Vazquez, a specialist at the institution.

(IMAGE VIA - depositphotos.com) Vazquez said the antibody, called Racotumomab, was proven in rigorous clinical trials in 2012 to increase survival rates among cancer patients, and has shown good safety and tolerance levels.

(IMAGE VIAdepositphotos.com) Vazquez said the antibody, called Racotumomab, was proven in rigorous clinical trials in 2012 to increase survival rates among cancer patients, and has shown good safety and tolerance levels.

The new vaccine reportedly combats lung carcinoma by reducing cancer cells and minimizing the presence of tumours. {More at Caribbean 360}

Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.

Comments

add a comment

Some HTML is OK

or, reply to this post via trackback.